SEC Form 4 · accession 0001209191-16-091520
Tobira Therapeutics, Inc. · TBRA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eckard Weber
Director
Period of report
Jan 12, 2016
Accepted (ET)
Jan 14, 2016 · 7:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001311596
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F1 | $7.91 | Jan 12, 2016 | A | 17,778 | A | — | Jan 11, 2026 | Common Stock | 17,778 | 17,778 | D |
Explanation of responses
- F1The shares will vest ratably over 12 months of continuous service beginning on January 1, 2016, subject to the terms of the Issuer's 2013 Equity Compensation Plan.